Filtros de búsqueda

Lista de obras de Nerea Allende-Vega

CD45 Isoform Profile Identifies Natural Killer (NK) Subsets with Differential Activity.

artículo científico publicado en 2016

Changes in metabolism affect expression of ABC transporters through ERK5 and depending on p53 status

artículo científico publicado en 2017

Chemical metabolic inhibitors for the treatment of blood-borne cancers

artículo científico publicado en 2014

Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors

scientific article published on 14 June 2018

Extracellular-signal-regulated kinase 5 modulates the antioxidant response by transcriptionally controlling Sirtuin 1 expression in leukemic cells.

artículo científico publicado en 2014

FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53

artículo científico publicado en 2009

Human Leukemic Cells performing Oxidative Phosphorylation (OXPHOS) Generate an Antioxidant Response Independently of Reactive Oxygen species (ROS) Production

artículo científico publicado en 2015

Identification and expression of genes involved in biosynthesis of L-oleandrose and its intermediate L-olivose in the oleandomycin producer Streptomyces antibioticus

artículo científico publicado en 2000

Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers

artículo científico publicado en 2015

MdmX is a substrate for the deubiquitinating enzyme USP2a

artículo científico publicado en 2010

Metabolic stress controls mutant p53 R248Q stability in acute myeloid leukemia cells

artículo científico publicado en 2019

Mitochondrial Complex I activity signals antioxidant response through ERK5.

artículo científico publicado en 2018

NK cell activation and recovery of NK cell subsets in lymphoma patients after obinutuzumab and lenalidomide treatment

scientific article published on 20 December 2017

Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53

artículo científico publicado en 2009

Targeting the ubiquitin-proteasome system to activate wild-type p53 for cancer therapy.

artículo científico publicado en 2009

The PDK1 Inhibitor Dichloroacetate Controls Cholesterol Homeostasis Through the ERK5/MEF2 Pathway

artículo científico publicado en 2017

The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2

artículo científico publicado en 2007

The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism

artículo científico publicado en 2015

Transcription factor TAFII250 phosphorylates the acidic domain of Mdm2 through recruitment of protein kinase CK2

scientific journal article

Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53

scientific journal article

p53 is activated in response to disruption of the pre-mRNA splicing machinery.

artículo científico publicado en 2012